Scarica l'app Stockscreener
1.21
4.72%
-0.06
Dopo l'orario di chiusura:
1.21
Precedente Chiudi:
$1.27
Aprire:
$1.24
Volume 24 ore:
183.02K
Relative Volume:
0.38
Capitalizzazione di mercato:
$31.61M
Reddito:
$2.83M
Utile/perdita netta:
$-7.95M
Rapporto P/E:
-0.4498
EPS:
-2.6898
Flusso di cassa netto:
$-7.01M
1 W Prestazione:
-12.95%
1M Prestazione:
-53.82%
6M Prestazione:
-90.66%
1 anno Prestazione:
-62.28%
Intervallo 1D:
$1.14
$1.28
Intervallo di 1 settimana:
$1.11
$1.38
Portata 52W:
$1.11
$99.75
Novabay Pharmaceuticals Inc Stock (NBY) Company Profile
Nome
Novabay Pharmaceuticals Inc
Settore
Industria
Telefono
510-899-8800
Indirizzo
2000 Powell Street, Suite 1150, Emeryville, CA
Compare NBY vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NBY
Novabay Pharmaceuticals Inc
|
1.21 | 31.61M | 2.83M | -7.95M | -7.01M | -2.6898 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.34 | 119.23B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
745.77 | 78.84B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
700.45 | 43.35B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
313.41 | 41.57B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
284.05 | 31.51B | 5.36B | 287.73M | 924.18M | 2.5229 |
Novabay Pharmaceuticals Inc Stock (NBY) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2019-09-18 | Iniziato | Ladenburg Thalmann | Buy |
| 2018-07-06 | Reiterato | H.C. Wainwright | Buy |
| 2017-11-15 | Reiterato | Laidlaw | Buy |
| 2017-06-05 | Iniziato | ROTH Capital | Buy |
| 2017-03-27 | Iniziato | Laidlaw | Buy |
| 2017-02-06 | Iniziato | Rodman & Renshaw | Buy |
| 2016-03-07 | Downgrade | Maxim Group | Buy → Hold |
| 2015-12-14 | Reiterato | Maxim Group | Buy |
| 2015-04-30 | Ripresa | Maxim Group | Buy |
| 2013-03-06 | Iniziato | Ascendiant Capital Markets | Strong Buy |
| 2008-01-03 | Iniziato | Dawson James | Speculative Buy |
Mostra tutto
Novabay Pharmaceuticals Inc Borsa (NBY) Ultime notizie
Gross profit of NovaBay Pharmaceuticals, Inc. – FWB:B9P1 - TradingView
NovaBay Pharmaceuticals Approves Issuance of 837 Million Shares and 2026 Equity Incentive Plan in Shareholder Vote - Minichart
NovaBay Pharmaceuticals shareholders approve charter amendments and stock issuance - Investing.com
NovaBay Pharma Expands Share Capital and Governance Flexibility - TipRanks
Novabay Pharmaceuticals: All six proposals, including share issuances and governance amendments, were approved - TradingView
Novabay Pharmaceuticals: All six proposals, including share issuances and governance changes, were approved - TradingView
Poplar Point cuts NovaBay (NBY) ownership below 5% reporting level - Stock Titan
Dividend Watch: Will NovaBay Pharmaceuticals Inc stock hit new highs in YEARPortfolio Update Report & Stock Market Timing Techniques - baoquankhu1.vn
Aug Decliners: Will NovaBay Pharmaceuticals Inc stock hit new highs in YEARTrade Entry Report & Daily Volume Surge Trade Alerts - baoquankhu1.vn
NBY Earnings History & Surprises | EPS & Revenue Results | NOVABAY PHARMACEUTICALS INC (NYSEARCA:NBY) - ChartMill
Breakouts Watch: What are the risks of holding NovaBay Pharmaceuticals IncPortfolio Growth Summary & Weekly Market Pulse Updates - baoquankhu1.vn
Gross margin % of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView
NBY SEC FilingsNovabay Pharma 10-K, 10-Q, 8-K Forms - Stock Titan
Net current asset value per share of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView
NovaBay Pharmaceuticals, Inc. Earnings and Revenue – GETTEX:B9P1 - TradingView
Cash per share of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView
NovaBay Pharmaceuticals (NYSEAMERICAN:NBY) Stock Price Passes Below 50-Day Moving AverageHere's What Happened - MarketBeat
Diluted net income available to common stockholders of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView
Debt to assets ratio of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView
Tangible book value per share of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView
Net current asset value per share of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView
Enterprise value to EBITDA ratio of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView
Free cash flow per share of NovaBay Pharmaceuticals, Inc. – FWB:B9P1 - TradingView
Operating income of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView
Price to cash flow ratio of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView
Diluted shares outstanding of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView
Total revenue of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView
Free cash flow of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView
Enterprise value of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView
Operating expenses (excl. COGS) of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView
Number of employees of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView
Gross margin % of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView
Operating margin % of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView
Return on invested capital % of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView
Diluted earnings per share (diluted EPS) of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView
EBITDA of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView
Free cash flow per share of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView
EBITDA per share of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView
Total liabilities of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView
Debt to equity ratio of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView
Cash from operating activities of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView
Long term debt to total equity ratio of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView
NovaBay Pharmaceuticals, Inc. Earnings and Revenue – MUN:B9P1 - TradingView
EBIT of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView
Operating income of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView
Average basic shares outstanding of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView
Total operating expenses of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView
Net debt of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView
Total liabilities & shareholders' equities of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView
Cost of goods sold of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView
Total equity of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView
Novabay Pharmaceuticals Inc Azioni (NBY) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.48%
1.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):